Vir Biotechnology (VIR) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Vir Biotechnology (VIR) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 8, 2023 (09:36)

Sector: Healthcare

The share price of Vir Biotechnology, Inc. (VIR) now

What analysts predict: $49.71
52-week High/Low: $31.78 / $18.05

50/200 Day Moving Average: $24.67 / $24.53

This figure corresponds to the Average Price over the previous 50/200 days. For Vir Biotechnology stocks, the 50-day moving average is the support level today.

For Vir Biotechnology stocks, the 200-day moving average is the support level today.

Are you interested in Vir Biotechnology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Vir Biotechnology stock price in 2023, 2024, 2025, 2026, 2027. How much will one Vir Biotechnology share be worth in 2023 - 2027?

When should I take profit in Vir Biotechnology stock? When should I record a loss on Vir Biotechnology stock? What are analysts' forecasts for Vir Biotechnology stock? What is the future of Vir Biotechnology stock? We forecast Vir Biotechnology stock performance using neural networks based on historical data on Vir Biotechnology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Vir Biotechnology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Vir Biotechnology shares. This happens once a day.




Historical and forecast chart of Vir Biotechnology stock

The chart below shows the historical price of Vir Biotechnology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Vir Biotechnology stock price can be found in the table below.

Long-term forecasts by years.

Vir Biotechnology daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 10 26.16 25.68 26.52 3.26
Jun 11 26.30 25.93 26.72 3.04
Jun 12 25.84 25.10 26.52 5.66
Jun 13 25.41 24.51 26.25 7.10
Jun 14 26.53 26.01 27.33 5.05
Jun 15 26.29 25.42 26.63 4.76
Jun 16 26.13 25.39 27.04 6.49
Jun 17 25.66 24.98 26.19 4.83
Jun 18 26.47 26.15 27.29 4.35
Jun 19 25.76 24.87 26.68 7.30
Jun 20 25.54 25.17 25.99 3.25
Jun 21 26.25 25.96 27.28 5.06
Jun 22 26.35 25.70 27.12 5.54
Jun 23 27.41 26.33 27.81 5.62
Jun 24 28.11 27.10 29.11 7.42
Jun 25 29.14 28.82 30.26 5.01
Jun 26 30.35 29.80 31.15 4.53
Jun 27 29.74 28.89 30.83 6.69
Jun 28 28.80 28.49 29.71 4.30
Jun 29 27.55 26.72 28.35 6.08
Jun 30 28.20 27.61 28.96 4.90
Jul 01 28.59 27.73 28.94 4.33
Jul 02 29.11 28.22 30.21 7.07
Jul 03 29.76 29.12 30.06 3.22
Jul 04 31.21 30.77 31.91 3.70
Jul 05 32.67 31.92 33.05 3.53
Jul 06 32.79 32.08 33.75 5.21
Jul 07 33.39 32.93 34.58 5.02
Jul 08 32.51 31.35 33.22 5.96
Jul 09 31.60 31.01 32.55 4.94

Vir Biotechnology Daily Price Targets


Vir Biotechnology Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $26.16.
Positive dynamics for Vir Biotechnology shares will prevail with possible volatility of 3.156%.
Pessimistic target level: 25.68
Optimistic target level: 26.52

Vir Biotechnology Stock Forecast 06-11-2023.

Forecast target price for 06-11-2023: $26.30.
Positive dynamics for Vir Biotechnology shares will prevail with possible volatility of 2.953%.
Pessimistic target level: 25.93
Optimistic target level: 26.72

Vir Biotechnology Stock Forecast 06-12-2023.

Forecast target price for 06-12-2023: $25.84.
Negative dynamics for Vir Biotechnology shares will prevail with possible volatility of 5.358%.
Pessimistic target level: 25.10
Optimistic target level: 26.52

Vir Biotechnology Stock Forecast 06-13-2023.

Forecast target price for 06-13-2023: $25.41.
Negative dynamics for Vir Biotechnology shares will prevail with possible volatility of 6.631%.
Pessimistic target level: 24.51
Optimistic target level: 26.25

Vir Biotechnology Stock Forecast 06-14-2023.

Forecast target price for 06-14-2023: $26.53.
Positive dynamics for Vir Biotechnology shares will prevail with possible volatility of 4.806%.
Pessimistic target level: 26.01
Optimistic target level: 27.33

Vir Biotechnology Stock Forecast 06-15-2023.

Forecast target price for 06-15-2023: $26.29.
Negative dynamics for Vir Biotechnology shares will prevail with possible volatility of 4.541%.
Pessimistic target level: 25.42
Optimistic target level: 26.63

VIR (VIR) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jul. 30.51 27.70 33.68 17.75
Aug. 33.32 30.65 37.18 17.56
Sep. 35.65 32.30 39.57 18.38
Oct. 35.86 33.78 39.23 13.89
Nov. 38.80 35.62 41.68 14.53
Dec. 40.51 36.78 45.53 19.22

Vir Biotechnology forecast for this year


Vir Biotechnology Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $30.5102. Pessimistic: $27.70. Optimistic: $33.68


Vir Biotechnology Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $33.3172. Pessimistic: $30.65. Optimistic: $37.18


Vir Biotechnology Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $35.6494. Pessimistic: $32.30. Optimistic: $39.57


Vir Biotechnology Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $35.8633. Pessimistic: $33.78. Optimistic: $39.23


Vir Biotechnology Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $38.804. Pessimistic: $35.62. Optimistic: $41.68


Vir Biotechnology Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $40.5114. Pessimistic: $36.78. Optimistic: $45.53



Vir Biotechnology (VIR) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 39.54 36.14 45.23 20.10
Feb 38.04 35.15 41.00 14.29
Mar 40.17 34.46 43.46 20.70
Apr 44.83 39.90 51.28 22.20
May 37.03 34.36 41.99 18.17
Jun 31.18 29.43 34.67 15.11
Jul 36.41 34.96 38.67 9.60
Aug 35.03 31.46 36.57 13.98
Sep 35.73 31.59 40.52 22.05
Oct 35.23 33.68 38.19 11.81
Nov 37.77 32.48 41.24 21.25
Dec 44.94 41.44 51.05 18.84

Vir Biotechnology (VIR) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 51.59 44.89 55.72 19.44
Feb 44.47 41.54 46.25 10.19
Mar 47.32 39.94 54.42 26.61
Apr 51.86 44.60 57.88 22.94
May 46.88 43.51 50.17 13.27
Jun 49.04 46.20 55.22 16.34
Jul 54.14 45.80 60.31 24.06
Aug 57.17 52.26 60.03 12.95
Sep 64.49 56.62 67.85 16.54
Oct 53.27 46.77 58.81 20.47
Nov 42.72 38.11 44.69 14.72
Dec 35.46 30.14 40.50 25.57

Vir Biotechnology (VIR) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 31.84 28.53 36.81 22.49
Feb 29.61 26.24 33.17 20.89
Mar 29.55 28.08 31.39 10.55
Apr 30.50 26.47 32.94 19.63
May 27.63 23.65 30.78 23.16
Jun 26.86 23.53 30.24 22.20
Jul 29.71 26.20 31.31 16.32
Aug 28.64 25.72 32.99 22.05
Sep 29.61 26.47 31.62 16.29
Oct 25.82 23.96 29.23 18.02
Nov 23.70 21.00 26.97 22.14
Dec 23.89 21.17 25.90 18.27

Vir Biotechnology (VIR) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 24.71 23.42 27.47 14.75
Feb 26.68 23.32 27.75 15.96
Mar 32.02 29.46 33.56 12.21
Apr 34.96 30.07 38.88 22.66
May 41.12 34.95 44.16 20.86
Jun 37.99 36.47 42.02 13.20
Jul 43.84 37.35 50.60 26.17
Aug 47.35 44.70 51.42 13.08
Sep 43.75 40.16 47.25 15.00
Oct 38.50 36.42 41.35 11.92
Nov 37.12 32.81 39.05 15.97
Dec 30.21 27.37 31.48 13.05

Vir Biotechnology information and performance

Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. He is developing VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis.

Vir Biotechnology Address

499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US

Market Capitalization: 3 656 232 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -276 062 016 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.16

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.585
Quarterly Revenue Growth YOY: -0.949
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 4.361

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.52

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.789

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 133977000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.